Cargando…
Characterization of In Vitro Resistance Development to the Novel Echinocandin CD101 in Candida Species
CD101 is a novel echinocandin with a long half-life undergoing clinical development for treatment of candidemia/invasive candidiasis and vulvovaginal candidiasis. The potential for and mechanisms underlying the development of resistance to CD101 in Candida species were investigated by using spontane...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Microbiology
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038289/ https://www.ncbi.nlm.nih.gov/pubmed/27480852 http://dx.doi.org/10.1128/AAC.00620-16 |